^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CEB-01

    i
    Other names: CEB-01, PLGA loaded with SN-38, poly(lactic-co-glycolic acid) loaded with SN-38
    Associations

    News

    Trials
    Company:
    Cebiotex
    Drug class:
    Topoisomerase I inhibitor
    Related drugs:
    Associations

    News

    Trials
    3ms
    CEB-01 in Locally Resectable Pancreatic Cancer (clinicaltrials.gov)
    P2, N=21, Recruiting, CEBIOTEX
    New P2 trial
    |
    CEB-01
    8ms
    CEB-01-RLS01-CT: First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma (clinicaltrials.gov)
    P1, N=21, Active, not recruiting, CEBIOTEX | Recruiting --> Active, not recruiting | Trial completion date: Mar 2024 --> May 2025 | Trial primary completion date: Dec 2023 --> May 2025
    Enrollment closed • Trial completion date • Trial primary completion date • Surgery • Metastases
    |
    CEB-01
    over1year
    CEB-01-RLS01-CT: First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma (clinicaltrials.gov)
    P1, N=21, Recruiting, CEBIOTEX | Trial completion date: Apr 2023 --> Mar 2024 | Trial primary completion date: Mar 2023 --> Dec 2023
    Trial completion date • Trial primary completion date
    |
    CEB-01